Clorox and Cleveland Clinic Release Guide to Help People Stay Safer at Home During COVID-19

The Clorox Company and Cleveland Clinic have released a second guide following the announcement of their partnership in July to support public health as society continues to face COVID-19.

“Safer at Home During the Coronavirus Pandemic” shares practices for households that can help people protect themselves, their loved ones and their communities from further spread of COVID-19. The free online guide incorporates general prevention information, resources on cleaning and disinfecting a home, tips on communicating with loved ones about the new realities and emotional challenges posed by the pandemic, and guidance on caring for family members who are sick with coronavirus. Many of the same steps can keep families healthy during the upcoming cold and flu season as well.

“As we continue to contend with the challenges from COVID-19, people are looking for guidance that will give them a sense of confidence and comfort that they’re taking the right steps to help them keep their families safe,” said Clorox Chair and CEO Benno Dorer. “Bringing together the knowledge and expertise we’ve each developed over the course of 100 years — for Clorox in serving the cleaning and disinfecting needs of households and for Cleveland Clinic in serving patient needs — is important. Our hope is that the guide will contribute to the collective action necessary to beat the pandemic.”

Added Cleveland Clinic Chief Clinical Transformation Officer James Merlino, M.D., “As we focus on protecting ourselves from COVID-19, it’s important we take precautions everywhere we go, including in our homes. This new guide offers advice that can prevent the spread of COVID-19, and addresses emotional well-being and ways to maintain social connections with friends and family while we are physically distant. Our organizations are committed to helping the community stay safe as we all continue to navigate a new normal during the ongoing COVID-19 pandemic.”

The first guide released in July as part of the Clorox-Cleveland Clinic partnership, “Six Building Blocks of a Robust Cleaning and Disinfection Program,” was focused on helping employers with training, effective product selection, and the development of robust cleaning and disinfection processes to create and maintain safer environments. The organizations are also involved in a partnership with United Airlines, the United CleanPlus program, to inform and guide new cleaning and safety protocols.

Cleveland Clinic offers resources and advisory support to help organizations safely resume operations during COVID-19. These resources include an employer website, COVID-19: Creating a Safe Workplace, which features a series of return to work guides developed for various industries. Cleveland Clinic also hosts a webinar series on topics ranging from infection prevention to employee resiliency.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version